185 related articles for article (PubMed ID: 9402181)
1. Severe CPT-11 toxicity in patients with Gilbert's syndrome: two case reports.
Wasserman E; Myara A; Lokiec F; Goldwasser F; Trivin F; Mahjoubi M; Misset JL; Cvitkovic E
Ann Oncol; 1997 Oct; 8(10):1049-51. PubMed ID: 9402181
[TBL] [Abstract][Full Text] [Related]
2. Genetic predisposition to the metabolism of irinotecan (CPT-11). Role of uridine diphosphate glucuronosyltransferase isoform 1A1 in the glucuronidation of its active metabolite (SN-38) in human liver microsomes.
Iyer L; King CD; Whitington PF; Green MD; Roy SK; Tephly TR; Coffman BL; Ratain MJ
J Clin Invest; 1998 Feb; 101(4):847-54. PubMed ID: 9466980
[TBL] [Abstract][Full Text] [Related]
3. Gilbert's Syndrome and irinotecan toxicity: combination with UDP-glucuronosyltransferase 1A7 variants increases risk.
Lankisch TO; Schulz C; Zwingers T; Erichsen TJ; Manns MP; Heinemann V; Strassburg CP
Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):695-701. PubMed ID: 18349289
[TBL] [Abstract][Full Text] [Related]
4. Combination of oxaliplatin plus irinotecan in patients with gastrointestinal tumors: results of two independent phase I studies with pharmacokinetics.
Wasserman E; Cuvier C; Lokiec F; Goldwasser F; Kalla S; Méry-Mignard D; Ouldkaci M; Besmaine A; Dupont-André G; Mahjoubi M; Marty M; Misset JL; Cvitkovic E
J Clin Oncol; 1999 Jun; 17(6):1751-9. PubMed ID: 10561212
[TBL] [Abstract][Full Text] [Related]
5. Genetic variation in bilirubin UPD-glucuronosyltransferase gene promoter and Gilbert's syndrome.
Monaghan G; Ryan M; Seddon R; Hume R; Burchell B
Lancet; 1996 Mar; 347(9001):578-81. PubMed ID: 8596320
[TBL] [Abstract][Full Text] [Related]
6. Pharmacology of irinotecan.
Kuhn JG
Oncology (Williston Park); 1998 Aug; 12(8 Suppl 6):39-42. PubMed ID: 9726089
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms of UDP-glucuronosyltransferase and pharmacokinetics of irinotecan.
Ando Y; Ueoka H; Sugiyama T; Ichiki M; Shimokata K; Hasegawa Y
Ther Drug Monit; 2002 Feb; 24(1):111-6. PubMed ID: 11805731
[TBL] [Abstract][Full Text] [Related]
8. The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome.
Bosma PJ; Chowdhury JR; Bakker C; Gantla S; de Boer A; Oostra BA; Lindhout D; Tytgat GN; Jansen PL; Oude Elferink RP
N Engl J Med; 1995 Nov; 333(18):1171-5. PubMed ID: 7565971
[TBL] [Abstract][Full Text] [Related]
9. UDP-glucuronosyltransferase in Gilbert's syndrome.
Debinski HS; Lee CS; Dhillon AP; Mackenzie P; Rhode J; Desmond PV
Pathology; 1996 Aug; 28(3):238-41. PubMed ID: 8912353
[TBL] [Abstract][Full Text] [Related]
10. Decreased glucuronidation and increased bioactivation of acetaminophen in Gilbert's syndrome.
de Morais SM; Uetrecht JP; Wells PG
Gastroenterology; 1992 Feb; 102(2):577-86. PubMed ID: 1732127
[TBL] [Abstract][Full Text] [Related]
11. [Assessment of total bilirubin or SN-38/SN-38G ratio as a predictor of severe irinotecan toxicity].
Tanaka H; Saito K; Mino K; Izumi K; Harada M; Isobe H
Gan To Kagaku Ryoho; 2009 Sep; 36(9):1505-9. PubMed ID: 19755821
[TBL] [Abstract][Full Text] [Related]
12. TATA-box mutant in the promoter of the uridine diphosphate glucuronosyltransferase gene in Italian patients with Gilbert's syndrome.
Sampietro M; Lupica L; Perrero L; Romano R; Molteni V; Fiorelli G
Ital J Gastroenterol Hepatol; 1998 Apr; 30(2):194-8. PubMed ID: 9675658
[TBL] [Abstract][Full Text] [Related]
13. Dual polymorphisms in UDP-glucuronosyltransferases 1A1 and 1A6: a novel mechanism for hyperserotoninaemia in Gilbert's syndrome mimicking carcinoid syndrome?
Lee P; Jones G; Seibel MJ
Eur J Gastroenterol Hepatol; 2007 Apr; 19(4):337-40. PubMed ID: 17353700
[TBL] [Abstract][Full Text] [Related]
14. Hepatotoxicity caused by mebendazole in a patient with Gilbert's syndrome.
Tolomeo M; Colomba C; Meli M; Cascio A
J Clin Pharm Ther; 2019 Dec; 44(6):985-987. PubMed ID: 31423600
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms of the UDP-glucuronosyl transferase 1A genes are associated with adverse events in cancer patients receiving irinotecan-based chemotherapy.
Inoue K; Sonobe M; Kawamura Y; Etoh T; Takagi M; Matsumura T; Kikuyama M; Kimura M; Minami S; Utsuki H; Yamazaki T; Suzuki T; Tsuji D; Hayashi H; Itoh K
Tohoku J Exp Med; 2013 Feb; 229(2):107-14. PubMed ID: 23303296
[TBL] [Abstract][Full Text] [Related]
16. [A study of polymorphism in UDP-glucuronosyltransferase 1 (UGT-1A1) promoter gene in Korean patients with Gilbert's syndrome].
Kim YH; Yeon JE; Jung GM; Kim HJ; Kim JS; Byun KS; Bak YT; Lee CH
Taehan Kan Hakhoe Chi; 2002 Jun; 8(2):132-8. PubMed ID: 12499798
[TBL] [Abstract][Full Text] [Related]
17. Metabolic fate of irinotecan in humans: correlation of glucuronidation with diarrhea.
Gupta E; Lestingi TM; Mick R; Ramirez J; Vokes EE; Ratain MJ
Cancer Res; 1994 Jul; 54(14):3723-5. PubMed ID: 8033091
[TBL] [Abstract][Full Text] [Related]
18. Phenotype-genotype correlation of in vitro SN-38 (active metabolite of irinotecan) and bilirubin glucuronidation in human liver tissue with UGT1A1 promoter polymorphism.
Iyer L; Hall D; Das S; Mortell MA; Ramírez J; Kim S; Di Rienzo A; Ratain MJ
Clin Pharmacol Ther; 1999 May; 65(5):576-82. PubMed ID: 10340924
[TBL] [Abstract][Full Text] [Related]
19. Genetic interactions in the pathogenesis of neonatal hyperbilirubinemia: Gilbert's Syndrome and glucose-6-phosphate dehydrogenase deficiency.
Kaplan M
J Perinatol; 2001 Dec; 21 Suppl 1():S30-4; discussion S35-9. PubMed ID: 11803413
[TBL] [Abstract][Full Text] [Related]
20. Molecular genetic basis of Gilbert's syndrome.
Burchell B; Hume R
J Gastroenterol Hepatol; 1999 Oct; 14(10):960-6. PubMed ID: 10530490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
